Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transformed basic, translational, and biomedical research. GenScript has partnered with pioneers pushing the boundaries in gene and cell engineering by providing its deep expertise in gene synthesis technologies. This first GenScript Gene & Cell Engineering Virtual Summit will showcase cutting-edge research from leaders leveraging synthetic biology technologies in drug-discovery, de novo protein design, and genome-editing.
GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy. For more information, visit www.genscript.com
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here